Skip to main content

Table 1 Clinical, biochemical and histopathological characteristics of patients with HBV associated diseases

From: Analysis of epithelial-mesenchymal transition markers in the histogenesis of hepatic progenitor cell in HBV-related liver diseases

Case

Sex

Age (years)

Disease

AST (IU/L)

ALT (IU/L)

Albumin (g/L)

Total bilirubin (μmol/L)

Platelet (×109/L)

Serum AFP (n/g/mL)

1

M

28

Hepatitis (Mild)

25

20

35

15.7

62

5.8

2

M

49

Hepatitis (Mild)

17

22

38

19.3

321

5.2

3

F

27

Hepatitis (Mild)

18

31

30

31.9

158

10

4

F

58

Hepatitis (Mild)

21

11

41

19.2

71

3.39

5

M

56

Hepatitis (Mild)

21

28

41

12.4

240

9.01

6

M

50

Hepatitis (Mild)

33

25

59

28.5

257

5.2

7

M

39

Hepatitis (Mild)

18

15

24

12

158

3.2

8

M

24

Hepatitis (Mild)

21

19

36

10.5

182

6.82

9

M

28

Hepatitis (Mild)

39

50

41

22.9

234

4.45

10

M

32

Hepatitis (Mild)

25

26

39

12.3

120

5.3

11

M

36

Hepatitis (Mild)

14

16

41

19.3

178

4.3

12

M

28

Hepatitis (Mild)

24

18

28

5.6

205

5.25

13

M

22

Hepatitis (Mild)

30

24

39

23.1

124

2.8

14

M

42

Hepatitis (Mild)

27

31

29

22.2

94

9.4

15

F

47

Hepatitis (Mild)

22

23

44

16

322

2.6

16

F

31

Hepatitis (Moderate)

43

41

28

21.3

167

10.2

17

F

38

Hepatitis (Moderate)

30

29

41

22.4

203

4.2

18

M

39

Hepatitis (Moderate)

18

17

30

21.4

205

6.2

19

M

41

Hepatitis (Moderate)

25

23

35

29

231

2.9

20

M

32

Hepatitis (Moderate)

31

29

27

17.4

160

1.84

21

M

28

Hepatitis (Moderate)

40

47

42

13.4

205

9.2

22

M

57

Hepatitis (Moderate)

22

19

42

21.8

265

4.28

23

F

41

Hepatitis (Moderate)

25

30

37

10.8

46

4.38

24

F

57

Hepatitis (Moderate)

21

12

19

31.3

254

3.21

25

M

39

Hepatitis (Moderate)

28

36

32

14.8

269

3.42

26

M

24

Hepatitis (Moderate)

39

21

57

19.9

189

3.02

27

M

60

Hepatitis (Moderate)

21

14

30

12.4

94

3.59

28

F

25

Hepatitis (Moderate)

32

21

51

20

109

2.5

29

F

39

Hepatitis (Moderate)

23

26

41

21.3

206

11.7

30

M

42

Hepatitis (Moderate)

48

35

44

25.1

207

8.2

31

F

39

Hepatitis (Severe)

54

92

26

35

307

10.6

32

M

52

Hepatitis (Severe)

35

37

18

15

184

1.23

33

M

36

Hepatitis (Severe)

23

71

39

23.1

159

9.08

34

M

21

Hepatitis (Severe)

35

49

25

38.1

93

3.57

35

M

31

Hepatitis (Severe)

28

58

62

29.5

222

4.9

36

M

39

Hepatitis (Severe)

23

31

31

16.6

81

2.2

37

M

26

Hepatitis (Severe)

18

24

50

20.7

152

8.1

38

F

27

Hepatitis (Severe)

29

42

41

29.1

121

2.7

39

M

40

Hepatitis (Severe)

7

15

25

15.2

106

3.9

40

M

47

Hepatitis (Severe)

37

27

31

8.2

83

4.6

41

M

33

Hepatitis (Severe)

24

62

28

43.2

119

3.12

42

M

51

Hepatitis (Severe)

16

36

32

24.3

132

7.9

43

M

32

Hepatitis (Severe)

41

61

18

16.8

182

10

44

F

41

Hepatitis (Severe)

66

34

30

38.7

204

4.33

45

M

25

Hepatitis (Severe)

20

15

50

23.4

310

3.8

46

F

51

non-HCC cirrhosis

12

41

48

36.2

49

9.2

47

M

47

non-HCC cirrhosis

31

21

42

36.9

69

4.9

48

M

38

non-HCC cirrhosis

27

33

26

13.9

891

4.27

49

M

40

non-HCC cirrhosis

47

36

40

26.1

104

21.34

50

F

41

non-HCC cirrhosis

30

14

28

40.3

71

3.6

51

M

55

non-HCC cirrhosis

38

10

28

28.4

158

6.87

52

F

60

non-HCC cirrhosis

20

51

32

11.4

175

5.74

53

M

49

non-HCC cirrhosis

44

27

35

19.3

92

3.56

54

M

54

non-HCC cirrhosis

20

42

21

14.3

60

7.24

55

M

59

non-HCC cirrhosis

25

26

46

18.5

127

2.3

56

M

48

non-HCC cirrhosis

19

15

39

21.2

115

6.8

57

F

32

non-HCC cirrhosis

307

342

49

29.3

110

7.6

58

M

56

non-HCC cirrhosis

22

19

26

20.6

172

8.3

59

F

53

non-HCC cirrhosis

31

26

24

18.2

77

2.48

60

F

47

non-HCC cirrhosis

20

25

51

21.9

51

3.9